Clinical Trial Update: Prospective Analysis of Introperative RegenLab PRP and Hyaluronic Acid in Patients With Knee ACL Tear [Phase 4]

View source ↗

Summary

Prospective Phase 4 trial update evaluating intraoperative RegenLab PRP and hyaluronic acid in patients with anterior cruciate ligament tears.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Cruciate Ligament Injury Tear
• Knee Pathology

Drugs mentioned

• Hyaluronic acid (hyaluronic acid)
• RegenLab PRP (platelet-rich plasma)

Snippet

Sponsor: Kaohsiung Veterans General Hospital. | Conditions: PRP, ACL | Phase 4 | Status: UNKNOWN